$PCYC News Biotech hammered as ETFs down 5%, while some

New Post Public Reply Private Reply Replies (0) Message Board

Jul 29, 2014 at 11:51 AM

$PCYC News

Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
S&P 500’s slow-motion breakout attempt ‘rages on’ 12:43 p.m. Feb. 27, 2014 - Michael Ashbaugh
FDA approval of leukemia treatment boosts shares of Pharmacyclics 2:57 p.m. Feb. 12, 2014 - Russ Britt
Pharmacyclics shares soar after panel says cancer drug met goals 1:09 p.m. Jan. 7, 2014 - Russ Britt
Gilead, Acura stand out on up day for stocks, Quest tumbles 11:27 a.m. Oct. 10, 2013 - Russ Britt
Health care leads S&P as St. Jude gets some good news from FDA 11:49 a.m. Oct. 4, 2013 - Russ Britt
Rough market day for Nektar, while Pharmacyclics and Regeneron soar 6:21 p.m. Sept. 26, 2013 - Russ Britt
Pharmacyclics shares jump after FDA accepts new cancer drug filing 12:09 p.m. Aug. 29, 2013 - Russ Britt
S&P 500 ventures to uncharted territory 12:21 p.m. July 18, 2013 - Michael Ashbaugh
Pharmacyclics seeks fast-track drug approval, makes double-digit gain 11:09 a.m. July 10, 2013 - Russ Britt
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
Positives continue to build for the Nasdaq 1:31 p.m. June 4, 2013 - The Trading Deck
For the medium-term trader, setups galore 11:39 a.m. May 14, 2013 - The Trading Deck
After the close: Big gains for Pharmacyclics, Biogen, Warner 5:39 p.m. May 13, 2013 - Russ Britt
FDA gives 'breakthrough' designation to Merck drug 9:10 p.m. April 23, 2013 - MarketWatch.com
Quest Diagnostics shares climb on glowing words from Goldman 12:26 p.m. April 11, 2013 - Russ Britt
Nasdaq clues suggest more upward valuation 1:46 p.m. March 8, 2013 - The Trading Deck
Leading stocks strut their stuff 11:39 a.m. March 5, 2013 - The Trading Deck
The return of the European bogeyman 1:58 p.m. Feb. 26, 2013 - The Trading Deck

Undervalued Biotech Stocks Beat the Index 6:54 a.m. Today - Barrons.com
Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog 5:15 p.m. July 28, 2014 - Zacks.com
Can the Rally in Pharmacyclics (PCYC) Shares Continue? - Tale of the Tape 8:37 a.m. July 24, 2014 - Zacks.com
7 Biotechnology Stocks to Buy Now 6:00 a.m. July 23, 2014 - InvestorPlace.com
Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion 2:06 p.m. July 21, 2014 - Seeking Alpha
Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More? 10:40 a.m. July 21, 2014 - Seeking Alpha
4 Top Biotechs Expected to Beat Earnings Expectations 9:17 a.m. July 16, 2014 - 247WallSt.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. July 16, 2014 - InvestorPlace.com
8 Biotechnology Stocks to Buy Now 5:45 a.m. July 9, 2014 - InvestorPlace.com
Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment 8:01 a.m. July 8, 2014 - Seeking Alpha
Pharmacyclics Inc. (PCYC): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. July 3, 2014 - Zacks.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. July 2, 2014 - InvestorPlace.com
Individual Investor Portfolio Update: Diversifying For Growth 1:40 a.m. July 1, 2014 - Seeking Alpha
Credit Suisse Raises Q2 Imbruvica Sales Forecast For Pharmacyclics 8:18 a.m. June 30, 2014 - benzinga.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. June 25, 2014 - InvestorPlace.com
'Fast Money' Recap: A Mixed Bag for Housing 5:00 a.m. June 25, 2014 - TheStreet.com
Cramer's Mad Money - 9 Things To Watch In The Week Ahead (6/20/14) 5:10 a.m. June 22, 2014 - Seeking Alpha
Fire Up The Immuno-Oncology Powerhouses: John McCamant 5:39 p.m. June 19, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 5:45 a.m. June 11, 2014 - InvestorPlace.com
Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog 6:45 p.m. June 10, 2014 - Zacks.com

Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 7:02 p.m. July 28, 2014 - PR Newswire - PRF
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications 1:18 p.m. July 28, 2014 - PR Newswire - PRF
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) for Treatment of Two Blood Cancers 8:52 a.m. July 25, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Critical Alerts For Intuitive Surgical, Estee Lauder, Dominos Pizza, Pharmacyclics, and Tata Motors Released By InvestorsObserver 9:31 a.m. July 2, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 7:10 a.m. June 11, 2014 - PR Newswire - PRF
Supplemental New Drug Application for IMBRUVICA® Accepted by the U.S. FDA and Priority Review Granted 8:00 a.m. June 9, 2014 - PR Newswire - PRF
IMBRUVICA® (ibrutinib) Combination with anti CD20 Antibody Shows Compelling Results in Heavily Pretreated Patients with CLL and Related Diseases 8:05 a.m. May 31, 2014 - PR Newswire - PRF
IMBRUVICA® (ibrutinib) Significantly Improves Progression Free Survival, Overall Survival and Overall Response as compared to Ofatumumab in Patients with Previously Treated CLL/SLL in its First Phase III study 8:05 a.m. May 31, 2014 - PR Newswire - PRF
Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen 5:10 a.m. May 29, 2014 - PR Newswire - PRF
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Pharmacyclics appoints Gregory R. Wade to lead Business Development 8:00 a.m. May 20, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 11:29 a.m. May 19, 2014 - PR Newswire - PRF
Study Results, Analyst Meetings, Upcoming Events, Financial Results, and Welfare Initiatives - Analyst Notes on Pharmacyclics, Thermo Fisher Scientific, Endo, Humana and Aetna 8:00 a.m. May 19, 2014 - PR Newswire - PRF
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
Pharmacyclics Highlights Important New Data for IMBRUVICA® (ibrutinib) in B-Cell Malignancies 6:22 p.m. May 14, 2014 - PR Newswire - PRF
Pharmacyclics Reports First Quarter 2014 Results 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Pharmacyclics Announces Date of Conference call to discuss Financial Results for First Quarter of 2014 10:45 a.m. April 25, 2014 - PR Newswire - PRF
Pre-market Equity Watch on the Health Care Sector -- Research on Isis Pharma, Pharmacyclics, Novo Nordisk, and Lannett 9:04 a.m. April 22, 2014 - PR Newswire - PRF
Pharmacyclics Announces Presentation of Phase III and Long Term Follow Up Data on IMBRUVICA™ in Chronic Lymphocytic Leukemia (CLL) at ASCO 11:45 a.m. April 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unlocking Insights: South Chicagoland Home Inspections

Sizing Up South Chicagoland Homes: What Really Gets Inspected In the world of real estate transactions, home inspections stand like grizzled veterans, proudly scrutinizing every nook and cranny before the ink dries on a property deed. Here in South Chicagoland, where the echoes of every frigid winter and sweltering summer linger, the process becomes a lifeline for buyers...

Haier Dives into AI-Powered Smart Homes at IFA 2026

A Bold Step into the Future of Smart Homes Hold onto your hats, folks! Haier is making waves at IFA 2026, showing off smart home tech that's not just buzzing with AI but adapting right before our eyes. 'Home of Intelligent Possibilities' isn't just a catchy phrase—it's Haier promising us homes that think for themselves. From laundry to cooking, they’re tweaking those...

Changhong's IFA 2026 Showcase: AI, Culture & Localization

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Ice-Rock Avalanches: Future Risks and Urgent Lessons

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Why Buyers Are Flocking to Whidbey Island Homes

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

China Hour Expands Chinese Media Footprint in Africa

An Ambitious Cross-Continental Media Play The airwaves are getting a new twist. This time, it's a blend of cultures, as China Hour makes an entrance in South Africa. That's right, folks—Jiangsu Broadcasting Corporation (JSBC) has set up camp alongside the South African Broadcasting Corporation (SABC), pushing a big media wave across the continent. If you've been...

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Affleck Joins Aflac in Unlikely Yet Fitting Alliance

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

VEVOR's Labor Day Salute to Home DIY Warriors

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...